SCHEMBL4014232

SCHEMBL4014232

CCCCC(C)C(C)C(CC(=O)O)NC(=O)CCC(C)CN

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G2C Q5R387 1/20 0.38
DNM1 Q05193 1/20 0.38
PLA2G10 O15496 2/20 0.36
NOD1 Q9Y239 4/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
FAAH O00519 2/20 0.35
MAPK1 P28482 1/20 0.35
SLC6A5 Q9Y345 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ASAH1 Q13510 1/20 0.32
ACER2 Q5QJU3 1/20 0.32
DPP4 P27487 1/20 0.32
DPP9 Q86TI2 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
MAPT P10636 1/20 0.32
GPR84 Q9NQS5 4/20 0.32
PDF Q9HBH1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4010160 0.92 DNM1 (0.33) PLA2G2CDNM1PLA2G10NOD1MEN1
SCHEMBL4005588 0.88 ENPEP (0.34) DNM1PLA2G10
SCHEMBL4014957 0.85 PLA2G2C (0.36) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL4015178 0.85 PLA2G2C (0.36) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL4009104 0.85 PLA2G2C (0.36) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL4010281 0.83 DPP7 (0.35) PLA2G2CPLA2G10SLC6A5DPP4DPP9
SCHEMBL4014262 0.80 FAAH (0.33) PLA2G2CDNM1FAAHALDH1A1ASAH1
SCHEMBL4008875 0.78 PLA2G10 (0.45) PLA2G2CDNM1PLA2G10NOD1MEN1
SCHEMBL4937977 0.78 GPR84 (0.39) PLA2G2CMAPK1MAPTGPR84PDF
SCHEMBL4937972 0.78 GPR84 (0.39) PLA2G2CMAPK1MAPTGPR84PDF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491835-B2 Prodrugs of amino acids with affinity for the α2δ-protein PFIZER INC (US) 2009-02-17 US claimed
EP-1670750-A1 PRODRUGS OF AMINO ACIDS WITH AFFINITY FOR THE ALPHA2DELTA- PROTEIN Warner-Lambert Company LLC (US) 2006-06-21 EP claimed
WO-2005030703-A1 PRODRUGS OF AMINO ACIDS WITH AFFINITY FOR THE α2δ- PROTEIN WARNER-LAMBERT COMPANY LLC (US) 2005-04-07 WO claimed
US-20050070483-A1 Prodrugs of amino acids with affinity for the alpha2delta-protein VIATRIS SPECIALTY LLC. 2005-03-31 US claimed
US-7491835-B2 Prodrugs of amino acids with affinity for the α2δ-protein PFIZER INC (US) 2009-02-17 US disclosed
EP-1670750-A1 PRODRUGS OF AMINO ACIDS WITH AFFINITY FOR THE ALPHA2DELTA- PROTEIN Warner-Lambert Company LLC (US) 2006-06-21 EP disclosed
WO-2005030703-A1 PRODRUGS OF AMINO ACIDS WITH AFFINITY FOR THE α2δ- PROTEIN WARNER-LAMBERT COMPANY LLC (US) 2005-04-07 WO disclosed
US-20050070483-A1 Prodrugs of amino acids with affinity for the alpha2delta-protein VIATRIS SPECIALTY LLC. 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070483-A1 Prodrugs of amino acids with affinity for the alpha2delta-protein SCN2A, OPRD1, SCN1A PLA2G2C 1607/4885DNM1 1445/4885PLA2G10 2762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.